These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 2232707)

  • 1. Photoaffinity labeling of human c-myc protein with deoxythymidine triphosphate.
    Satav JG; Modak MJ; Studzinski GP
    Lab Invest; 1990 Oct; 63(4):551-6. PubMed ID: 2232707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct photoaffinity labeling of ribonucleotide reductase from Escherichia coli using dTTP: characterization of the photoproducts.
    Kierdaszuk B; Eriksson S
    Biochemistry; 1988 Jun; 27(13):4952-6. PubMed ID: 3048394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Members of the poly (rC) binding protein family stimulate the activity of the c-myc internal ribosome entry segment in vitro and in vivo.
    Evans JR; Mitchell SA; Spriggs KA; Ostrowski J; Bomsztyk K; Ostarek D; Willis AE
    Oncogene; 2003 Sep; 22(39):8012-20. PubMed ID: 12970749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PuF/NM23-H2/NDPK-B transactivates a human c-myc promoter-CAT gene via a functional nuclease hypersensitive element.
    Berberich SJ; Postel EH
    Oncogene; 1995 Jun; 10(12):2343-7. PubMed ID: 7784082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.
    Kinney EL; Tanida S; Rodrigue AA; Johnson JK; Tompkins VS; Sakamuro D
    J Cell Physiol; 2008 Sep; 216(3):621-31. PubMed ID: 18348166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA binding of Myc/Max/Mad network complexes to oligonucleotides containing two E box elements: c-Myc/Max heterodimers do not bind DNA cooperatively.
    Vervoorts J; Lüscher B
    Biol Chem; 1999 Sep; 380(9):1121-6. PubMed ID: 10543451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photoaffinity labeling of the thymidine triphosphate binding domain in Escherichia coli DNA polymerase I: identification of histidine-881 as the site of cross-linking.
    Pandey VN; Williams KR; Stone KL; Modak MJ
    Biochemistry; 1987 Dec; 26(24):7744-8. PubMed ID: 3322406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
    Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
    Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct visualization of the binding of c-Myc/Max heterodimeric b-HLH-LZ to E-box sequences on the hTERT promoter.
    Lebel R; McDuff FO; Lavigne P; Grandbois M
    Biochemistry; 2007 Sep; 46(36):10279-86. PubMed ID: 17705400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-myc-enhanced S phase entry in keratinocytes is associated with positive and negative effects on cyclin-dependent kinases.
    Alexandrow MG; Moses HL
    J Cell Biochem; 1998 Sep; 70(4):528-42. PubMed ID: 9712150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteins encoded by the c-myc oncogene: analysis of c-myc protein degradation.
    Lüscher B; Eisenman RN
    Princess Takamatsu Symp; 1986; 17():291-301. PubMed ID: 3332017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of c-Myc and Max binding to the c-myc promoter: evidence that autosuppression occurs via an indirect mechanism.
    Buckle RS; Méchali M
    Oncogene; 1995 Mar; 10(6):1249-55. PubMed ID: 7700652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of c-myc oncogene expression by phorbol ester and interferon-gamma: appraisal by flow cytometry.
    Mohamed AN; Nakeff A; Mohammad RM; KuKuruga M; al-Katib A
    Oncogene; 1988 Oct; 3(4):429-35. PubMed ID: 3152600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid-polylysine carrier improves efficacy of c-myc antisense oligodeoxynucleotides on human melanoma (M14) cells.
    Ginobbi P; Geiser TA; Ombres D; Citro G
    Anticancer Res; 1997; 17(1A):29-35. PubMed ID: 9066627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N and C-terminal sub-regions in the c-Myc transactivation region and their joint role in creating versatility in folding and binding.
    Fladvad M; Zhou K; Moshref A; Pursglove S; Säfsten P; Sunnerhagen M
    J Mol Biol; 2005 Feb; 346(1):175-89. PubMed ID: 15663936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of c-Myc protein in murine myeloid leukaemia cells during growth and after irradiation.
    Popović-Hadzija M; Poljak-Blazi M; Pavelić K
    Anticancer Res; 1997; 17(2A):1089-92. PubMed ID: 9137454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRD-BP shields c-myc and MDR-1 RNA from endonucleolytic attack by a mammalian endoribonuclease.
    Sparanese D; Lee CH
    Nucleic Acids Res; 2007; 35(4):1209-21. PubMed ID: 17264115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ECA39 is regulated by c-Myc in human and by a Jun/Fos homolog, Gcn4, in yeast.
    Ben-Yosef T; Yanuka O; Benvenisty N
    Oncogene; 1996 Nov; 13(9):1859-66. PubMed ID: 8934531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mmip-2, a novel RING finger protein that interacts with mad members of the Myc oncoprotein network.
    Yin XY; Gupta K; Han WP; Levitan ES; Prochownik EV
    Oncogene; 1999 Nov; 18(48):6621-34. PubMed ID: 10597267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation sites mapping in the N-terminal domain of c-myc modulate its transforming potential.
    Henriksson M; Bakardjiev A; Klein G; Lüscher B
    Oncogene; 1993 Dec; 8(12):3199-209. PubMed ID: 8247524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.